Massimo Lopez

A. Kuten, M. Krzakowski, B. Dubray, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Cyproterone acetate in advanced male breast cancer

Massimo Lopez, A. Barduagni, 1982 .

Cyproterone acetate in the treatment of metastatic cancer of the male breast

Massimo Lopez, 1985, Cancer.

Sequential Subcutaneous Thymopentin, Interferon Alpha-2A and Interleukin-2 in Metastatic Renal Cell Cancer

P. Vici, L. di Lauro, Massimo Lopez, 1995, Tumori.

Oral idarubicin in non-Hodgkin's lymphomas

Massimo Lopez, P. Papaldo, L. Lauro, 1986, Investigational New Drugs.

Phase II trial with oral idarubicin in advanced breast cancer

Massimo Lopez, P. Papaldo, L. Lauro, 2004, Investigational New Drugs.

Dose-Intensive E pirubicin-Based C hemotherapy I s S uperior to a n I ntensive I ntravenous C yclophosphamide , Methotrexate, a nd F luorouracil R egimen i n M etastatic Breast C ancer: A R andomized M ultinational S tudy

S. Ackland, A. Antón, A. Ezzat, 2001 .

A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer

A. Bianco, D. Giannarelli, S. Fazio, 1989, Cancer.

Thallium‐201 Scintigraphy and Chemotherapeutic Response in Rhabdomyosarcoma

Massimo Lopez, CARLO L. MAINI, ANNA TOFANI, 1994, Clinical nuclear medicine.

Phase I–II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines

G. Bepler, F. Cognetti, A. Fabi, 2011, Cancer Chemotherapy and Pharmacology.

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.

S. Barni, R. Labianca, G. Luporini, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First-line treatment with epirubicin and vinorelbine in metastatic breast cancer.

M. Valerio, N. Gebbia, G. Colucci, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increasing single epirubicin doses in advanced soft tissue sarcomas.

P. Vici, L. di Lauro, Massimo Lopez, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of epirubicin in advanced malignant melanoma

C. Perno, Massimo Lopez, P. Papaldo, 2004, Investigational New Drugs.

Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide.

S. Di Cosimo, A. Fabi, P. Carlini, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Medical Oncologist’s Point of View

Massimo Lopez, S. Fattoruso, L. Giacinti, 2009 .

A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines

M. Mottolese, P. Foggi, D. Giannarelli, 2008, Oncology.

5-Fluorouracil, adriamycin, and BCNU (FAB) combination chemotherapy for advanced gastric cancer

Massimo Lopez, P. Papaldo, L. Lauro, 2004, Cancer Chemotherapy and Pharmacology.

Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma

D. Giannarelli, D. Sergi, L. di Lauro, 2009, Journal of experimental & clinical cancer research : CR.

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

Bingshu E. Chen, R. Gray, P. Lønning, 2023, The Lancet.

5-Fluorouracil, adriamycin, and BCNU (FAB) combination for advanced gastric cancer

C. Perno, Massimo Lopez, P. Papaldo, 1984 .

Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).

D. Galetta, P. Mazzanti, C. Pinto, 2006, Lung cancer.

Paraneoplastic Raynaud phenomenon with digital necrosis associated with hyperhomocysteinemia and antiphospholipid antibodies.

M. Rinaldi, L. Perracchio, A. Morrone, 2007, Archives of Dermatology.

Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study.

S. Ackland, A. Antón, A. Ezzat, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

5-Fluorouracil, Adriamycin and Cyclophosphamide Combined with High-Dose Medroxyprogesterone Acetate in Advanced Breast Cancer

C. Perno, L. di Lauro, Massimo Lopez, 1983, Tumori.

Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.

M. Mottolese, R. Cavaliere, A. Tofani, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Paclitaxel Activity in Anthracycline Refractory Breast Cancer Patients

A. Amodio, P. Vici, L. di Lauro, 1997, Tumori.

Breast cancer and timing of surgery during menstrual cycle: a 5‐year analysis of 248 premenopausal women

M. Milella, F. Cognetti, A. Fabi, 1999, Breast Cancer Research and Treatment.

Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial.

C. Porta, O. Bertetto, F. Testore, 2011, International journal of oncology.

Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study

V. Adamo, S. Palazzo, C. Ficorella, 2005, British Journal of Cancer.

Controlled study of DTIC versus DTIC plus epirubicin in metastatic malignant melanoma

C. Perno, Massimo Lopez, P. Papaldo, 2004, Investigational New Drugs.